Posted on

IIROC Trading Halt – NUMI

IIROC Trading Halt – NUMI

TORONTO, April 11, 2022 /CNW/ – The following issues have been halted by IIROC:

Company: Numinus Wellness Inc.

TSX Symbol: NUMI

All Issues: Yes

Reason: Pending News

Halt Time (ET): 8:00 AM

IIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. IIROC is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.

SOURCE Investment Industry Regulatory Organization of Canada (IIROC) – Halts/Resumptions

For further information: For further information about IIROC’s trading halt policy, please see Trading Halts & Timely Disclosure (https://www.iiroc.ca/news-and-publications/halts-and-resumptions) at www.iiroc.ca under the Halts and Resumptions tab. Please note that IIROC staff cannot provide any information about a specific halt beyond what is contained in this halt notice. For general information about IIROC, contact IIROC’s Complaints and Inquiries team at inquiries@iiroc.ca or 1-877-442-4322 (Option 2). For company-related enquiries, contact the company directly.

Posted on

Universal Ibogaine Announces Approval Of Trading On OTCQB Venture Market

Universal Ibogaine Announces Approval Of Trading On Otcqb Venture Market

Calgary, AB – February 28, 2022 – Universal Ibogaine Inc. (TSXV:IBO and OTCQB: IBOGF) (“UI” or the “Company”) a life sciences company with a mission to transform the world of addiction treatment through medicalized ibogaine and a state of the art ongoing care program, is pleased to announce that its common shares have been approved for trading on the OTCQB Venture Market (the “OTCQB”) under the ticker “IBOGF”.  UI will continue to trade in Canada on the TSX Venture Exchange under its current ticker symbol IBO. 

The UI common shares trading in the United States have also been approved for DTC eligibility.

The OTCQB Venture Market is for early stage and developing U.S. and international companies, which are current in their reporting and undergo an annual verification and management certification process.  Investors can find Real-Time quotes and market information for the Company on www.otcmarkets.com

Universal Ibogaine CEO Nick Karos stated: “Accessing the vast USA market of retail and institutional investors  through the OTC platform will provide our current and future shareholders enhanced liquidity and expanded global exposure for the Company, which will assist with our future financing and growth plans.  We look forward to working with the OTC Markets Group, as the USA is a key future addiction treatment market for us, with over 100,000 lives lost to opioid overdose last year alone.”   

OTC Markets Group Inc. operates the OTCQX® Best Market, the OTCQB® Venture Market and the Pink® Open Market for 11,000 U.S. and global securities. Through OTC Link® ATS and OTC Link ECN, it connects a diverse network of broker-dealers that provide liquidity and execution services. It enables investors to easily trade through the broker of their choice and empowers companies to improve the quality of information available for investors.


About Universal Ibogaine Inc.
UI is a life sciences company, with a mission to demonstrate the safety and efficacy of its ibogaine based drug detox protocol through a Canadian Clinical Trial, and ultimately to utilize that protocol around the globe through future licensing agreements.  UI is concurrently developing a state of the art holistic addiction treatment protocol at its Kelburn Clinic that, which when paired with the planned ibogaine detox protocol, is intended to revolutionize the way we treat addiction and drastically improve the lives of individuals and families affected by addiction.

NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS


‎This news release may contain forward-looking statements and information. Forward-looking information is frequently characterized by words such ‎as “plans”, “expect”, “project”, “intend”, “will”, “believe”, “anticipate”, “estimate”, “scheduled”, ‎‎”potential”, or other similar words, or statements that certain events or conditions “may”, “should” or ‎‎”could” occur. The forward-looking statements and information are based
on certain key expectations ‎and assumptions made by UI. Although UI believes that the expectations and assumptions on which the forward-‎looking statements are based are reasonable, undue reliance should not be placed on the forward-‎looking statements because UI can give no assurance that they will prove to be correct.

Since ‎forward-looking statements address future events and conditions, by their very nature they involve ‎inherent risks and uncertainties. Actual results could differ materially from those currently anticipated ‎due to a number of factors and risks, which include, but are not limited to, risks that required ‎regulatory approvals are not obtained. The reader is cautioned that assumptions used in the ‎preparation of such information, although considered reasonable by UI at the time of ‎preparation, may prove to be incorrect
and readers are cautioned not to place undue reliance on ‎forward-looking information, which speaks only to conditions as of the date hereof. UI does not ‎undertake any obligation to release publicly any revisions to forward-looking information contained ‎herein to reflect events or circumstances that occur after the date hereof or to reflect the occurrence ‎of unanticipated events, except as may be required under applicable securities laws. ‎


For further information:


Investor Relations: Dugan Selkirk, IR Manager
dugan.selkirk@universalibogaine.com


Media Contact: Cathy Fernandes, Director – Marketing & Communications
cathy.fernandes@universalibogaine.com

Posted on

Canbud Distribution Corp. Announces Intention to Change Name and Stock Symbol

Canbud Distribution Corp. Announces Intention to Change Name and Stock Symbol

Toronto, Ontario–(Newsfile Corp. – February 14, 2022) – Canbud Distribution Corp. (CSE: CBDX) (FSE: CDO) (“Canbud” or the “Company“) announces that it intends to change its name to “Steep Hill Inc.” and its stock symbol to “STPH”. The proposed Company name and stock symbol changes are subject to approval from the Canadian Securities Exchange and its receipt of new CUSIP and ISIN numbers. Assuming the satisfaction of these requirements, the Company intends to issue a subsequent news release announcing the name change and the expected effective date of trading under the new name and symbol.

Sameet Kanade, Chief Executive Officer of the Company, commented: “The “Steep Hill” name is one of the longest standing brands in the North American analytical testing market within the cannabis sector. Following the closing of the Company’s acquisition of US-based, Steep Hill Inc., the Company’s focus is on continuing growth in the North American market. The proposed corporate name change is aimed to provide the Company with a stronger and more specific brand identity, which is associated with the significant technical and scientific expertise within the Company.”

About Canbud Distribution Corp.

Canbud is an early-stage science and technology company focused on providing products and services, including analytical testing services within the hemp and cannabis market sectors. The Company’s focus is on two areas: science and technology, by providing science-backed differentiated products and services that are critical within these sectors; and quality and compliance, by offering services that assist its customers to offer products and services that meet expected standards of quality, safety and compliance.

Notice Regarding Forward-Looking Information

The information in this news release includes certain information and statements about management’s view of future events, expectations, plans and prospects that constitute forward looking statements. Forward looking statements in this news release include, but are not limited to, management’s expectations with respect to carrying out the planned name and stock symbol changes and the effects thereof. These statements are based upon assumptions that are subject to significant risks and uncertainties, including assumptions about the operations, financial condition and future performance of the Company’s business as a whole. Although the Company considers these assumptions to be reasonable based on information currently available to them, they may prove to be incorrect, and the forward-looking statements in this news release are subject to numerous risks, uncertainties and other factors that may cause future results to differ materially from those expressed or implied in such forward-looking statements, including the impact of the ongoing COVID 19 pandemic on the Company’s operations and growth plans. Although the Company’s management believes that the expectations reflected in forward looking statements are reasonable, the Company can give no assurances that the expectations of any forward-looking statements will prove to be correct. Except as required by law, the Company disclaims any intention and assume no obligation to update or revise any forward-looking statements to reflect actual results, whether as a result of new information, future events, changes in assumptions, changes in factors affecting such forward looking statements or otherwise.

For further information, please contact:

Sameet Kanade, CEO
Tel: 416 847 7312
Email: ir@canbudcorp.com

Posted on

YourWay Cannabis Brands Commences Trading on the OTCQB Venture Market in the United States

YourWay Cannabis Brands Commences Trading on the OTCQB Venture Market in the United States

Broadens audience of investors, allowing YourWay to expand shareholder base and improve awareness, access, and liquidity

VANCOUVER, BC, Feb. 10, 2022 /PRNewswire/ – YourWay Cannabis Brands Inc. (CSE: YOUR) (OTC: YOURF) (FSE: HOB) (the “Company” or “YourWay“), a multi-state and consumer-centric House of Brands committed to redefining the way consumers and cannabis brands interact, today announced the Company’s common shares are trading on the OTCQB Venture Market (“OTCQB“) in the United States under the symbol, “YOURF”.  

“Listing on the OTCQB is another milestone for YourWay as we continue to broaden awareness of the Company’s activities in the United States, including highlighting exciting growth opportunities for the Company,” said Jakob Ripshtein, Chairman, Board of Directors, YourWay. “By exposing YourWay to a larger market of investors, we look forward to expanding the Company’s shareholder base, and improving awareness, access and liquidity.”

YourWay’s common shares will continue to trade under the symbol “YOUR” on the Canadian Securities Exchange, and “HOB” on the Frankfurt Stock Exchange.  

About OTC Markets Group Inc.

OTC Markets Group Inc. (OTCQX: OTCM) (“OTC Markets Group“) operates the OTCQX® Best Market, the OTCQB® Venture Market and the Pink® Open Market for over 11,000 U.S. and global securities. Through its regulated OTC Link® Alternative Trading Systems, OTC Markets Group connects a diverse network of broker-dealers that provide liquidity and execution services. OTC Markets Group enables investors to easily trade through the broker of their choice and empowers companies to improve the quality of information available for their investors. To learn more about how OTC Markets Group creates better informed and more efficient markets, visit www.otcmarkets.com. 

About YourWay Cannabis Brands

YourWay Cannabis Brands is a publicly traded multi-state operator with sales and operations in Arizona and California. Through building their own brands, partnering with others, and providing white-labelled product, they are dedicated to expanding their reach; remolding the cannabis industry and ultimately, redefining the way consumers and cannabis brands interact.

YourWay aims to connect with the cannabis consumer on a deeper level, utilizing decades of brand-building expertise and an integral understanding of the customer experience to create an intuitive suite of branded products that closely aligns with consumer need states. The YourWay portfolio is an all-encompassing house of brands designed to create a sense of belonging for every cannabis consumer regardless of their relationship with the plant. Please visit www.yourwaycannabis.com for the latest news and information about YourWay and its brands.

Website:  www.yourwaycannabis.com 

SOURCE YourWay Cannabis Brands